Equulus Therapeutics was founded with a mission to turn the promise of psychedelics into real-world therapeutics that transform patients' lives and set a new standard in neuroscience healthcare.

Equulus is taking a transdiagnostic approach to the development of therapeutics for CNS disorders, transcending standard diagnostic categories and tied to disease-driving physiology. 

Here's a look at the pitch deck designed by Vip Sitaraman for Equulus, used to raise capital to fund drug development and clinical trials.